Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
80%-100%, Zurich, fixed-term Are you passionate about turning biomedical data into actionable insights? Do you excel at coordinating cross-disciplinary development and transforming research tools
-
using emerging non-invasive exhalomics (exhaled breath metabolomics) approach. The research program integrates animal experiments with advanced analytical techniques and bioinformatics to enhance
-
80%-100%, Zurich, fixed-term The National Center of Competence in Research, NCCR Catalysis aims to develop skills, tools, and technologies that facilitate the transition towards a carbon-neutral
-
, ACHIEVE consortium The primary focus of this role is to serve as the Knowledge and Technology Transfer (KTT) Expert within the ACHIEVE consortium as part of the SWEET funding programme of the Swiss Federal
-
the research of the group on its website. Project background The candidate for the Post-doctoral researcher position is expected to develop their own research project in the area of digital
-
for Scientific Council meetings: Coordinate inputs and prepare documents requiring the Vice President’s contribution ahead of ScC meetings; ensure materials are complete, accurate and submitted on time. Support to
-
block courses-covering key topics in comparative evolutionary anthropology, primatology, and the biological and cultural evolution of gender relations. Emphasis will be placed on methodologically rigorous
-
of highest priority. The mission concept study will finalize the required satellite architecture, conduct key technical trades, and finalize the overall mission development plan and implementation
-
this. The goals of this PhD project will be to develop new 3D model schemes to represent the formation and evolution of ozone in fire plumes, to test these simulations against airborne, surface, and satellite
-
Group, an ISO 17025 accredited laboratory. The group is doing research on malaria molecular epidemiology, with a focus on drug resistance, and is also providing services to drug developers for molecular